China's Biopharmas Buffeted by Clashing Market Dynamics

Loeb & Loeb partner Lewis Ho is quoted on regulation changes in China’s pharmaceutical industry and their effect on new drug approvals and the health care market.  

Click here to read the article on BioWorld’s website.